| Ytd | -57.57% | |
| 1y | -93.09% |
| Open | 3.12 | Prev Close | 3.04 | Low | 3.02 | High | 3.21 | Mkt Cap | 217.55K |
| Vol | 13.37K | Avg Vol | 787.64K | EPS | -43.34 | P/E | -0.07 | Forward P/E | -0.89 |
| Beta | 1.49 | Short Ratio | 0.44 | Inst. Own | 6.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 3.02 | 200-d Avg | 6.28 | 1yr Est | 2.17 |
SLE News
SANTA MONICA, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”),
Gainers TNL Mediagene (NASDAQ:TNMG) shares increased by 114.0% to $0.77 during Tuesday's pre-ma
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced the initiation of PRESERVE, a Phase 4, m
Gainers Super League Enterprise (NASDAQ:SLE) stock increased by 13.1% to $3.45 during Tuesday's
Johnson and Johnson presents new IMAAVYÂ (nipocalimab-aahu) data at European Academy of Neurology (E
Partnership Unlocks Premium, Audience-First Advergaming Units Across the World's Largest Portfolio o
SANTA MONICA, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”),
Johnson and Johnson presents new data further reinforcing the role of nipocalimab in lowering the au
Johnson and Johnson late-breaking results show nipocalimab significantly reduced systemic lupus eryt
Nipocalimab – the first and only neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus
Super League Enterprise (SLE) could be a great choice for investors looking to buy stocks that have
SANTA MONICA, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), a
Super League Enterprise Inc (NASDAQ:SLE) shares are charging higher on Tuesday, building on upward m
President Trump's 12-word remark, “I don't think about Americans' financial situation, I don't think
Super League Enterprise, Inc. (SLE) Q1 2026 Earnings Call Transcript
Super League Enterprise (SLE) came out with a quarterly loss of $1.77 per share versus the Zacks Con
Super League Enterprise, Inc. (NASDAQ:SLE) reported first-quarter earnings Friday before the market
Gross revenue growth and improved gross margin reflects strengthening operating momentum Strong cash
SANTA MONICA, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), a
SANTA MONICA, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), a
SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-sta
Transaction will add pro-forma profitable revenue, enhance predictability of financial performance,
A wave of analyst downgrades, outlook resets and company-specific headlines pushed last week's b
